LCMSMS Solutions For Steroid Analysis Dan Blake Manager, Clinical Applications For Research Use Only. Not for use in diagnostic procedures. RUO-MKT-18-1166-A Agenda • Special considerations for steroid analysis • Methods of Steroid analysis 1: Simple & Fast ‒ Testosterone iMethod™ ‒ Online Extraction with 2DLC and simple sample processing ‒ Low Level Estrogen iMethod™ • Improving Selectivity with Ion Mobility • Methods of Steroid Analysis 2: Extending the coverage ‒ Steroid Panel iMethod™ ‒ Commercial Kits • Summary of and conclusions from the different approaches 2 © 2016 SCIEX RUO-MKT-18-1166 A Special considerations for steroid analysis • Traditional immunoassays, while convenient, are unreliable for reasons previously discussed • Varying sample volumes available ‒ Paediatric/neonatal samples • Pressures of sample number and turnaround time demand a fast and easy to setup method • Again, similar pressures require the use of rapid, automatable extraction procedures ‒ ‒ ‒ ‒ 4 Ideally some form of protein precipitation Liquid Liquid extraction is an option but not appropriate for all laboratories SPE is an option but can be costly Derivitisation, for example with dansyl chloride, is an option for challenging steroids but should be considered as a last resort. © 2016 SCIEX RUO-MKT-18-1166 A • What Steroids to analyse? The LC/MS/MS method should give us as much information as possible However, increasing the number of analytes could potentially increase the complexity of the assay 5 © 2016 SCIEX RUO-MKT-18-1166 A The “ideal” LC/MS/MS Steroid Application • The convenience of an immunoassay style kit approach • Sensitive enough to assay the lowest level steroids ‒ The “which instrument” part of the question • Able to cope with sample volume and throughput demands • The highest control ‒ Wide dynamic range standard curve ‒ Deuterated internal standards, for each analyte if possible ‒ Ability to utilise traceable Quality Control material 6 © 2016 SCIEX RUO-MKT-18-1166 A Testosterone iMethod™ • Testosterone is one of the most widely measured steroids • Measurement of testosterone is used to research a variety of disorders, such as congenital adrenal hyperplasia and hypogonadism. • Measurement of the typical levels in men is straightforward; however, measurement of the low levels present in women and children can be especially challenging. • SCIEX provides solutions for routine analysis for both circumstances. ‒ Simple male testosterone assay on the API3200™ platform using protein precipitation ‒ Low level (female) assay on the API5000™ or Triple Quad 5500™ using more thorough sample preparation 8 © 2016 SCIEX RUO-MKT-18-1166 A Testosterone iMethod™, API3200™ Data from a 3.4 nMol/L testosterone sample analyzed using an SCIEX API 3200™ LC/MS/MS System. 9 © 2016 SCIEX RUO-MKT-18-1166 A Testosterone iMethod™, API5000™ Data from a 0.069 nMol/L testosterone sample analyzed using an SCIEX API 5000™ LC/MS/MS System. 10 © 2016 SCIEX RUO-MKT-18-1166 A Testosterone iMethod™ Online Extraction with 2DLC and simple sample processing • A simple method for analysis of a small number of routinely measured steroids has been proposed • The method employs a simple protein precipitation with direct injection onto a 2DLC system (no need for offline sample concentration) • The remainder of the sample cleanup process is performed on a trapping column, followed by a reversed flow gradient onto a common C18 HPLC column, with a total runtime of 5 minutes • As a consequence, sample preparation time is kept to a minimum and sample throughput is maximised • The trap column is reusable, with a lifetime in excess of 1000 injections 12 © 2016 SCIEX RUO-MKT-18-1166 A Proposed Flow and Plumbing diagram for 2DLC Steroids method GRADIENT PUMPS A/B Column Oven TRAPPING COLUMN MS System Analytical Column Switching Valve 5 AUTOSAMPLER VALVE 6 ISOCRATIC LOAD PUMP C 1 10 2 9 3 Valve position A: (Analyte Loading onto Trapping Column) Switching Valve: Time(min) Valve Position 4 8 7 5 6 WASTE 13 © 2016 SCIEX RUO-MKT-18-1166 A WASTE Valve position B: 0.0 A (Analyte Elution from SPE Column onto Analytical Column) 1.0 B 5.5 A Extracted Steroid sample, approx 0.15nmol/L, Analysed by 2DLC approach Testosterone 17-OH-P 11-Deoxycortisol Androstenedione 14 © 2016 SCIEX RUO-MKT-18-1166 A Low Level Estrogen iMethod™ The Importance of Estrogens • Estrogen is an entire class of related female sex hormones: estrone (E1) estradiol (E2), and estriol (E3) • Estrone (E1) is widespread throughout the body. It is the only one of estrogens that’s present in any amount in women after menopause. • Estradiol (E2) is the primary sex hormone of childbearing women. It is formed from developing ovarian follicles. Estradiol is responsible for female characteristics and sexual functioning. Also, estradiol is important to women’s bone health. Estradiol contributes to most gynecologic problems and even female cancers. • Estriol (E3) is made from the placenta. It’s important only during pregnancy. 16 © 2016 SCIEX RUO-MKT-18-1166 A Estrone and Estradiol: Conditions: • Instrumentation ‒ API 5000™ and SCIEX Triple Quad™ 5500 Mass Spectrometers ‒ Shimadzu Prominence 20A and Agilent 1200 integrated systems • Method Information ‒ ‒ ‒ ‒ 17 500 µL sample volume required Liquid-liquid extraction without derivatization Clinically relevant dynamic range of 5-500 pg/mL 6 minute total run time © 2016 SCIEX RUO-MKT-18-1166 A Estrone and Estradiol: Lower Limit of Quantitation Estrone 5 pg/mL LLOQ, S/N=22 18 © 2016 SCIEX RUO-MKT-18-1166 A Estradiol 5 pg/mL LLOQ, S/N=19 Estrone and Estradiol: Precision and Accuracy Estrone (E1) Sample (pg/mL) Estradiol (E2) %CV % Accuracy Day 1-3 Day 1-3 LLOQ (5) 9 104 Low QC (15) 3 High QC (100) ULOQ (500) Sample (pg/mL) %CV % Accuracy Day 1-3 Day 1-3 LLOQ (5) 10 101 104 Low QC (15) 4 96 3 101 High QC (100) 5 102 3 100 ULOQ (500) 4 101 •Estrone (inter-day) •Estradiol (inter-day) •LLOQ CV’s ≤ 9% ,QC’s CV’s ≤ 5% •LLOQ CV’s ≤ 10% ,QC’s CV’s ≤ 5% •Accuracy deviation ≤ 4% •Accuracy deviation ≤ 4% 19 © 2016 SCIEX RUO-MKT-18-1166 A Estrone and Estradiol: Linearity Estrone Estradiol Clinically relevant dynamic range 5-500 pg/ml, R≤ 0.999 20 © 2016 SCIEX RUO-MKT-18-1166 A Estrone and Estradiol: Summary • The method was verified internally across laboratories for analytical analysis • LLOQ with suitable signal to noise (20) • Inter-day Precision and Accuracy ‒ LLOQ CVs ≤ 10% ,QCs CV’s ≤ 5% ‒ Accuracy Deviation ±4% • Control samples at clinically relevant low and high concentrations (5-500 pg/mL) with linear response r ≤ 0.999 • Liquid-Liquid extraction without derivatization • 6 minutes run time 21 © 2016 SCIEX RUO-MKT-18-1166 A Improving Selectivity with Ion Mobility Ion Mobility to improve selectivity • There are many different ways to achieve improved selectivity in applications of LC-MS/MS, including: ‒ Improved chromatography ‒ Tandem mass spectrometry (MS/MS, or even higher MS3) ‒ High-resolution mass spectrometry ‒ More up-front sample cleanup • In many applications of LC-MS/MS, mass measurements alone (even high resolution) cannot provide sufficient selectivity ‒ Isobaric interferences may have the same “exact mass” as analyte ions ‒ Interferences may have common fragment ions ‒ Chemical background may pose a challenge • The SelexION™ ion mobility technology provides an orthogonal means of separating / filtering ions prior to, and independent of, MS/MS analysis. 23 © 2016 SCIEX RUO-MKT-18-1166 A SelexION™ Ion Mobility Device Components: Existing ion path New hardware 24 © 2016 SCIEX RUO-MKT-18-1166 A SelexION™ Ion Mobility Device Components: 1. Orifice Plate 2. Ion Mobility Cell Robust, easy-to-install, hardware components: 25 No tools required No cables No need to break vacuum Installation in about 2 minutes © 2016 SCIEX RUO-MKT-18-1166 A 3. Curtain Plate Tuning the SelexION™ Ion Mobility Device t2 ions in transport gas =0 0 to mass spectrometer 0 t1 Separation Voltage (SV) Compensation Voltage (COV) (E) K ( E ) K (0) K (0) Ions migrate towards one of the planar electrodes – If an ion’s high-field mobility K(E) is larger than its low-field mobility K(0), >0 – If an ion’s low-field mobility K(0) is larger than it high-field mobility K(E), <0 Any ion can be steered back onto the center-line, by application of a compound-specific DC compensation voltage (CV). 26 © 2016 SCIEX RUO-MKT-18-1166 A Tuning the SelexION™ Ion Mobility Device Rel. Int. (%) 100% The ion residence time, and hence the resolution of the ion mobility device, can be controlled. 50% CV peak widths range from approximately 0.5 – 2.5 V FWHM. 0% -14 -12 -10 -8 -6 -4 -2 0 Compensation Voltage (CV) 2 4 6 8 10 12 In infusion mode, the compensation voltage (CV) parameter is ramped in order to determine the optimized value. Note that this is analogous to tuning any other compound-specific parameter, e.g. the collision energy (CE) 27 © 2016 SCIEX RUO-MKT-18-1166 A 14 Mixture of 6 androgens in 60:40 Methanol:Water Sample chromatogram from QTRAP® 5500 LC/MS/MS system XIC of +MRM (6 pairs): Exp 1, 287.2/97.0 Da ID: ASD from Sample 15 (Androgens mix 5) of Quant-RestekC18-150msec.wiff (Turbo Spr... 5-ASD DHEA 1.29e5 1.25e5 (~10ng/mL) (~30ng/mL) 1.20e5 1.15e5 DHT T 1.10e5 1.05e5 (~4ng/mL) (~400pg/mL) 1.00e5 9.50e4 9.00e4 AND 3.17 In te n s ity , c p s 98% B (~10ng/mL) 8.50e4 8.00e4 7.50e4 ASD 7.00e4 (~500pg/mL) Max. 8.7e4 cps. 6.50e4 6.00e4 80% B 5.50e4 75% B 5.00e4 4.50e4 4.00e4 3.50e4 3.00e4 2.50e4 55% B 2.00e4 1.50e4 1.00e4 5000.00 0.00 0.0 28 0.5 1.0 1.5 2.0 2.5 © 2016 SCIEX RUO-MKT-18-1166 A 3.0 3.5 4.0 4.5 5.0 Time, min 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 Structures of two androgens, DHEA and T • Testosterone, C19H28O2 CH3 O Low ionization efficiencies Common precursor ion masses (m/z 289) CH3 H Similar fragmentation patterns H Similar chromatographic H retention properties HO Dehydroepiandrosterone (DHEA), C19H28O2 OH CH3 CH3 H O 29 © 2016 SCIEX RUO-MKT-18-1166 A H H MS/MS of DHEA and Testosterone (m/z 289) (A) MS/MS fragmentation pattern (Collision Energy ramp) for DHEA CH3 CH3 O H H Used for MRM transition H HO (B) MS/MS fragmentation pattern (Collision Energy ramp) for Testosterone Used for MRM transition OH CH3 CH3 H O 30 © 2016 SCIEX RUO-MKT-18-1166 A H H Resolving DHEA and Testosterone using the SelexION™ Ion Mobility Device SelexION™ device “off” Interference caused by the presence of Testosterone SelexION™ device “on” (a) (b) No interference caused by the presence of Testosterone DHEA (289.0/271.1) DHEA (289.0/253) DHEA (289.0/271.1) DHEA (289.0/253) a) There is a significant interference in the MRM channel for DHEA, caused by the presence of testosterone b) When the SelexION™ ion mobility device is employed the interference is completely removed. Thus there is no longer a need for chromatographic separation, and run-times can be reduced dramatically. 31 © 2016 SCIEX RUO-MKT-18-1166 A Liquid-Liquid Extraction (LLE) – LC-MS/MS 289/97 289/109 Testosterone peak in female serum Interference Testosterone peak in female serum Interference Area ratio ~ 23 Expected ratio =1.23 Liquid-Liquid Extraction (LLE) – LC-MS/MS with SelexION™ Technology 289/109 289/97 Area ratio = 1.28 Expected ratio =1.23 32 © 2016 SCIEX RUO-MKT-18-1166 A x Protein Precipitation (PPT) – LC-MS/MS 289/109 Testosterone peak in female serum 289/97 Testosterone peak in female serum Protein Precipitation (PPT) – LC-MS/MS with SelexION™ Technology 289/109 33 © 2016 SCIEX RUO-MKT-18-1166 A 289/97 STD Curve in Serum Sample using the SelexION™Ion Mobility Device (sample preparation = PPT) 4 female 4 serum samples from females subjects Accuracy 96- 105% Sample Sample Average Ion Ratio (97/109) STDEV %CV 34 Neat (N=28) Serum PPT (N=25) Serum LLE (N=25) Neat (n=28) Patient PPT (n=25) Patient LLE (n=25) © 2016 SCIEX RUO-MKT-18-1166 A 1.23 0.04 3.44 1.28 0.07 5.47 1.24 0.04 3.12 SelexIon performance for Estrogen Analysis p s Serum (40 uL) by PPT and no SelexIon™ Max. 6.8e4 cps. c XIC of -MRM (3 pairs): 275.200/147.100 Da ID: d4-E2 from Sample 1 (PlasmaNew ppt 15) of 111220-NoDms-PlasNew-15.wiff (Turbo Spray) i t y , 9000 8000 s 7000 t e n 6000 5000 I n 4000 3000 2000 1000 0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 XIC of -MRM (3 pairs): 271.200/145.100 Da ID: E2 from Sa... offset by -2.05 min 4.0 E2 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 Time, min Max. 3710.6 cps. XIC of -MRM (3 pairs): 269.200/145.100 Da ID: E1 from Sa... offset by -2.05 min In te n s ity , c p s In te n s ity , c p s 7.82 7.98 800 600 400 11.0 11.5 Max. 1.4e4 cps. 8000 8.68 E1 7000 6000 5000 4000 3000 2000 200 7.76 1000 0 0.0 35 10.5 9000 8.72 1000 10.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 Time, min © 2016 SCIEX RUO-MKT-18-1166 A 8.0 9.0 10.0 11.0 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 Time, min 8.0 9.0 10.0 11.0 SelexIon performance for Estrogen Analysis p s Serum (40 uL) by PPT with SelexIon™ Max. 2313.0 cps. c XIC of -MRM (3 pairs): 269.200/145.100 Da ID: E1 from Sample 6 (plasma 15ppt) of 111222-Plasma15-demifast.wiff (Turbo Spray) 8.66 i t y , 2313 n s 2000 t e 1500 I n 1000 500 0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 XIC of -MRM (3 pairs): 271.200/145.100 Da ID: E2 from Sa... 8.64 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 Time, min Max. 289.3 cps. XIC of -MRM (3 pairs): 269.200/145.100 Da ID: E1 from Sa... E2 200 150 100 10.5 11.0 11.5 Max. 2313.0 cps. 8.66 E1 2000 1500 1000 500 50 36 10.0 2313 250 0 0.0 5.5 In te n s ity , c p s In te n s ity , c p s 289 5.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 Time, min © 2016 SCIEX RUO-MKT-18-1166 A 8.0 9.0 10.0 11.0 0 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 Time, min 8.0 9.0 10.0 11.0 Spiked plasma sample analyzed without SelexION™ (A) and with SelexION™ Technology (B). The light blue marked regions defined where signal and noise were collected. E1: S/N (1 sigma): 77 E2: S/N (1 sigma): 27 E1: S/N (1 sigma): 462 E2: S/N (1 sigma): 162 37 © 2016 SCIEX RUO-MKT-18-1166 A Steroid Panel iMethod™ • Increasing the number of compounds analysed in an assay is a perfect way of maximising potential return on investment • LC-MS/MS is ideally suited to this approach • The SCIEX Steroid Panel iMethod™ allows simultaneous analysis of 10 commonly measured steroids and also 25Hydroxyvitamin D3 • Sample preparation is simple protein precipitation with dilution • LC separation is required in order to keep the sample preparation to a minimum, run time is 12.5 minutes • In order to achieve the required sensitivity for all compounds assayed, this method is designed for use on the API5000™and Triple Quad 5500™instruments 39 © 2016 SCIEX RUO-MKT-18-1166 A Steroid Panel iMethod™, Extracted sample at ULOQ 40 © 2016 SCIEX RUO-MKT-18-1166 A Performance Data, Steroid Panel iMethod™ 41 © 2016 SCIEX RUO-MKT-18-1166 A • SCIEX offers several solutions for steroid analysis • Various forces will determine which approach is needed ‒ ‒ ‒ ‒ ‒ Analysis of less challenging steroids Requirements for analysis of multiple compounds Sensitivity requirements on challenging steroids Desire for the convenience of a kit-based assay Multiplexing with additional applications • From this, the appropriate method and instrument can be matched to the analytical requirements 42 © 2016 SCIEX RUO-MKT-18-1166 A Trademarks/Licensing SCIEX is doing business as SCIEX. For Research Use Only. Not for use in diagnostic procedures. © 2016 SCIEX. The trademarks mentioned herein are the property of SCIEX Pte. Ltd. or their respective owners. SCIEX™ is being used under license. 43 © 2016 SCIEX RUO-MKT-18-1166 A
© Copyright 2026 Paperzz